Class information for:
Level 1: TUMOR ASSOCIATED TRYPSIN INHIBITOR//TATI//PEC 60

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
22252 331 31.5 72%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1045 9625 BOWMAN BIRK INHIBITOR//PROTEASE ACTIVATED RECEPTOR//CYCLOTIDES

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TUMOR ASSOCIATED TRYPSIN INHIBITOR Author keyword 38 86% 6% 19
2 TATI Author keyword 15 54% 6% 19
3 PEC 60 Author keyword 11 100% 2% 6
4 SERINE PROTEASE INHIBITOR KAZAL TYPE 1 SPINK1 Author keyword 3 100% 1% 3
5 PANCREATIC TRYPSINOGEN Author keyword 3 60% 1% 3
6 TRYPSIN 2 Author keyword 3 60% 1% 3
7 PANCREATIC SECRETORY TRYPSIN INHIBITOR Author keyword 2 20% 3% 11
8 PRSS3 Author keyword 2 67% 1% 2
9 TUMOR ASSOCIATED TRYPSIN INHIBITOR TATI Author keyword 2 67% 1% 2
10 TUMOUR ASSOCIATED TRYPSIN INHIBITOR Author keyword 2 67% 1% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 TUMOR ASSOCIATED TRYPSIN INHIBITOR 38 86% 6% 19 Search TUMOR+ASSOCIATED+TRYPSIN+INHIBITOR Search TUMOR+ASSOCIATED+TRYPSIN+INHIBITOR
2 TATI 15 54% 6% 19 Search TATI Search TATI
3 PEC 60 11 100% 2% 6 Search PEC+60 Search PEC+60
4 SERINE PROTEASE INHIBITOR KAZAL TYPE 1 SPINK1 3 100% 1% 3 Search SERINE+PROTEASE+INHIBITOR+KAZAL+TYPE+1+SPINK1 Search SERINE+PROTEASE+INHIBITOR+KAZAL+TYPE+1+SPINK1
5 PANCREATIC TRYPSINOGEN 3 60% 1% 3 Search PANCREATIC+TRYPSINOGEN Search PANCREATIC+TRYPSINOGEN
6 TRYPSIN 2 3 60% 1% 3 Search TRYPSIN+2 Search TRYPSIN+2
7 PANCREATIC SECRETORY TRYPSIN INHIBITOR 2 20% 3% 11 Search PANCREATIC+SECRETORY+TRYPSIN+INHIBITOR Search PANCREATIC+SECRETORY+TRYPSIN+INHIBITOR
8 PRSS3 2 67% 1% 2 Search PRSS3 Search PRSS3
9 TUMOR ASSOCIATED TRYPSIN INHIBITOR TATI 2 67% 1% 2 Search TUMOR+ASSOCIATED+TRYPSIN+INHIBITOR+TATI Search TUMOR+ASSOCIATED+TRYPSIN+INHIBITOR+TATI
10 TUMOUR ASSOCIATED TRYPSIN INHIBITOR 2 67% 1% 2 Search TUMOUR+ASSOCIATED+TRYPSIN+INHIBITOR Search TUMOUR+ASSOCIATED+TRYPSIN+INHIBITOR

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TUMOR ASSOCIATED TRYPSIN 33 77% 7% 23
2 PANCREATIC TRYPSINOGEN 23 86% 4% 12
3 TATI 12 52% 5% 17
4 60 RESIDUE INTESTINAL PEPTIDE 11 100% 2% 6
5 MESOTRYPSIN 9 83% 2% 5
6 PROCOLLAGENASES 6 71% 2% 5
7 HUMAN MESOTRYPSIN 6 53% 2% 8
8 PSTI 6 41% 3% 11
9 SECRETORY TRYPSIN INHIBITOR 4 15% 7% 22
10 CYST FLUID 2 13% 5% 18

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
TATI as a biomarker 2014 2 167 53%
Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor 2006 45 195 51%
Tumor-associated trypsin inhibitor 2002 42 45 73%
Role of intrapancreatic SPINK1/Spink3 expression in the development of pancreatitis 2012 10 64 30%
Trypsins and their role in carcinoma growth 2006 35 91 40%
Human pancreatic secretory trypsin inhibitor - Distribution, actions and possible role in mucosal integrity and repair 1998 33 27 63%
Trypsin in colorectal cancer: molecular biological mechanisms of proliferation, invasion, and metastasis 2006 51 101 27%
The Roles of Serine Protease Inhibitor Kazal Type 1 (SPINK1) in Pancreatic Diseases 2011 10 60 35%
Human trypsinogens in the pancreas and in cancer 2010 3 43 44%
Proenzyme therapy of cancer 2005 14 80 14%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 GASTROENTEROL HEMATOL ONCOL RHEUMATOL 1 100% 0.6% 2
2 CAMBRIDGE HEPATOBILIARY UNIT 1 50% 0.3% 1
3 CANC METATASIS 1 50% 0.3% 1
4 ORAL DIAGNOST PATHOL 1 50% 0.3% 1
5 PANKREATITIS FOR UNGS 1 50% 0.3% 1
6 UROL MALMO LUND 1 50% 0.3% 1
7 BIOSCI KITA KU 0 33% 0.3% 1
8 CLIN TRANSPLANTAT LIVER SURG 0 33% 0.3% 1
9 SURG PREOPERAT SCI UROL ANDROL 0 33% 0.3% 1
10 MOL CLIN ONCOL SOLID TUMORS 0 20% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000179825 KAZAL TYPE SERINE PROTEINASE INHIBITOR//PACIFASTIN//KAZAL TYPE
2 0.0000151558 ENTEROPEPTIDASE//DUODENASE//ENTEROKINASE
3 0.0000108352 DING PROTEIN//DING PROTEINS//HUMAN PHOSPHATE BINDING PROTEIN
4 0.0000102848 URINARY TRYPSIN INHIBITOR//BIKUNIN//ULINASTATIN
5 0.0000087415 ECOTIN//STREPTOMYCES ERYTHRAEUS//BOVINE BETA TRYPSIN
6 0.0000087304 SERUM PANCREATIC ENZYMES//PANCREATIC HYPERENZYMEMIA//BENIGN PANCREATIC HYPERENZYMEMIA
7 0.0000082729 PROTEASE ACTIVATED RECEPTOR//PROTEASE ACTIVATED RECEPTORS//THROMBIN RECEPTOR
8 0.0000078435 PANCREATIC SECRETION//BILE PANCREATIC JUICE DIVERSION//CCK 58
9 0.0000078022 CHRONIC PANCREATITIS//HEREDITARY PANCREATITIS//PRSS1
10 0.0000072092 ECRG4//ECRG2//ECRG1